NewsBenzingaFDA Clears QIAGEN's Gram-Negative QIAstat-Dx Bloodstream Panel, Joining Gram-Positive And Fungal Panel To Cover 33 Pathogen Targets And 28 Resistance Marker FDA Clears QIAGEN's Gram-Negative QIAstat-Dx Bloodstream Panel, Joining Gram-Positive And Fungal Panel To Cover 33 Pathogen Targets And 28 Resistance Marker Benzinga 2026.09.28 07:10 (GMT+0) Open on Benzinga Other news Wayfair Q2 2026 Earnings Call Transcript Campbell's: Profit Continues To Fall, But The Stock Is Becoming Interesting (NASDAQ:CPB) Michael Burry Warns AI Models May Never Reach AGI As Synthetic Data Risks Triggering Model Collapse: 'Understanding Cannot Exist Unless...' McCormick & Company’s Quarterly Earnings Preview: What You Need to Know Is Qnity Electronics Stock Outperforming the Dow? Elon Musk Says Starship Is Just ‘2 to 3 Years Away’ From Hourly Flights—Reaffirms Sept. 28 Launch for First Orbital Attempt
Michael Burry Warns AI Models May Never Reach AGI As Synthetic Data Risks Triggering Model Collapse: 'Understanding Cannot Exist Unless...'
Elon Musk Says Starship Is Just ‘2 to 3 Years Away’ From Hourly Flights—Reaffirms Sept. 28 Launch for First Orbital Attempt
